PNC Financial Services Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,700
Closed -$18.7K 4837
2024
Q3
$18.7K Hold
2,700
﹤0.01% 3541
2024
Q2
$21.1K Hold
2,700
﹤0.01% 3456
2024
Q1
$19.2K Hold
2,700
﹤0.01% 3470
2023
Q4
$18.1K Sell
2,700
-90
-3% -$507 ﹤0.01% 3493
2023
Q3
$15.7K Hold
2,790
﹤0.01% 3553
2023
Q2
$15.4K Hold
2,790
﹤0.01% 3663
2023
Q1
$17.4K Sell
2,790
-30
-1% -$167 ﹤0.01% 3561
2022
Q4
$13.1K Hold
2,820
﹤0.01% 3660
2022
Q3
$13K Hold
2,820
﹤0.01% 3636
2022
Q2
$17K Hold
2,820
﹤0.01% 3570
2022
Q1
$55K Sell
2,820
-44
-2% -$1.01K ﹤0.01% 3049
2021
Q4
$93K Buy
2,864
+160
+6% +$6.44K ﹤0.01% 2736
2021
Q3
$111K Buy
2,704
+4
+0.1% +$145 ﹤0.01% 2579
2021
Q2
$97K Buy
2,700
+2,560
+1,829% +$94.5K ﹤0.01% 2674
2021
Q1
$5K Buy
+140
New +$6.3K ﹤0.01% 3816

Other funds holding GDRX

PNC Financial Services Group's GDRX Position: Q4 2024 in Review

PNC Financial Services Group sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 2,700 shares — an estimated $18.7K sold.

PNC Financial Services Group first reported a position in GDRX in Q1 2021 and held it in 15 quarters. The position peaked at $111K in Q3 2021. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • PNC Financial Services Group reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 2,700 GoodRx Holdings shares in Q4 2024, an estimated $18.7K.
  • PNC Financial Services Group first reported a position in GoodRx Holdings in Q1 2021 and held it in 15 quarters.
  • PNC Financial Services Group's GoodRx Holdings position peaked at $111K in Q3 2021.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on PNC Financial Services Group's 13F filing for Q4 2024, filed 7 Feb 2025.